title: [Prevalence of hepatitis B and C virus, HTLV-1 and HIV in type B lymphoproliferative syndromes in Gabon].
abstract: B lymphoproliferative disorders (B-LPD) are the most frequent types of lymphoid malignancies encountered in Gabon where HCV, HBV, HTLV-I and HIV are highly prevalent and all known for lymphotropism. Prevalences of HBs Ag, antibodies to HCV, HTLV-I and HIV were compared in 40 patients (21 men, 19 women; 17 < age < 75 years) with newly diagnosed B-LPD (low grade lymphoma = 6, intermediate grade = 21, high grade = 8: chronic lymphocytic leukaemia = 5) and 160 age and sex-matched controls. None of the B-LPD patients had got transfusion or parenteral care from the onset of symptoms to the inclusion day. In the B-LPD group, 13 patients had HBs Ag and antibodies to HCV, HIV and HTLV-1 were detected in 11, 6 and 10 subjects. In monovariate analysis, HBs Ag, antibodies to HIV or HTLV-1 were risk factors for B-LPD but antibodies to HCV were not associated with such diseases. Multivariate analysis showed only a relationship between HBs Ag and B-LPD (OR = 3.86; IC: 1.11-13.48). In such patients, reactivation of B hepatitis by treatment of B-LBD may be an important concern. If a background poor immune system could explain both susceptibility to long standing virus carriage and lymphoma development, a participating action of the HBV in lymphomagenesis could not be excluded.
authors.affiliation: Institut de médecine tropicale, service de santé des armées, Le Pharo, Marseille, France. jlucperret@infonie.fr
authors.forename: J L
authors.initials: JL
authors.lastname: Perret
authors.forename: J B
authors.initials: JB
authors.lastname: Moussavou-Kombila
authors.forename: E
authors.initials: E
authors.lastname: Delaporte
authors.forename: D
authors.initials: D
authors.lastname: Minko-Mi-Etoua
authors.forename: L F
authors.initials: LF
authors.lastname: Pemba
authors.forename: J B
authors.initials: JB
authors.lastname: Boguikouma
authors.forename: J R
authors.initials: JR
authors.lastname: Nzenze
authors.forename: X
authors.initials: X
authors.lastname: Deparis
authors.forename: B
authors.initials: B
authors.lastname: Larouzé
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000914:Antibodies, Viral / Q000097:blood; D005260:Female; D005681:Gabon; D006678:HIV / Q000276:immunology / Q000302:isolation & purification*; D016174:Hepacivirus / Q000276:immunology / Q000302:isolation & purification*; D006514:Hepatitis B Surface Antigens / Q000097:blood; D006515:Hepatitis B virus / Q000276:immunology / Q000302:isolation & purification*; D015368:Human T-lymphotropic virus 1 / Q000276:immunology / Q000302:isolation & purification*; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000821:virology; D008223:Lymphoma / Q000821:virology; D008232:Lymphoproliferative Disorders / Q000821:virology*; D008297:Male; D008875:Middle Aged
chemical_list: D000914:Antibodies, Viral; D006514:Hepatitis B Surface Antigens